Oligodendroglioma Clinical Trials

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
N
Recruiting
  • 1p/19q Co-deletion
  • +8 more
  • IMRT (Intensity-Modulated Radiation Therapy)
  • +2 more
  • Birmingham, Alabama
  • +26 more
2022-04-04
Apr 4, 2022
W
Recruiting
  • Glioma
  • +8 more
  • MRI-guided laser ablation
  • +4 more
  • Saint Louis, Missouri
    Washington University School of Medicine
2022-03-15
Mar 15, 2022
C
Recruiting
  • Central Nervous System Neoplasms
  • +22 more
  • Bethesda, Maryland
    National Institutes of Health
2022-03-01
Mar 1, 2022
W
Recruiting
  • Glioma
  • +5 more
  • Part 1 Survey Group
  • Part 2 Focus Group
  • Winston-Salem, North Carolina
    Wake Forest Baptist Comprehensive Cancer Center
2022-01-31
Jan 31, 2022
O
Recruiting
  • Oligodendroglioma
  • +2 more
  • Radiation therapy
  • Oslo, Norway
    Oslo University Hospital
2022-01-14
Jan 14, 2022
H
Recruiting
  • Oligodendroglioma
  • +2 more
  • PCV chemotherapy
  • Radiotherapy and PCV chemotherapy
  • Amiens, France
  • +25 more
2021-12-31
Dec 31, 2021
W
Recruiting
  • Anatomic Stage IV Breast Cancer AJCC v8
  • +7 more
  • Winston-Salem, North Carolina
    Wake Forest University Health Sciences
2021-12-22
Dec 22, 2021
N
Active, not recruiting
  • Giant Cell Glioblastoma
  • +5 more
  • Bevacizumab
  • +4 more
  • Anchorage, Alaska
  • +243 more
2021-12-21
Dec 21, 2021
U
Active, not recruiting
  • Oligodendroglioma
  • +5 more
  • GBM6-AD and poly-ICLC before and after surgery
  • GBM6-AD and poly-ICLC after surgery only
  • San Francisco, California
    University of California
2021-11-15
Nov 15, 2021
M
Recruiting
  • Anaplastic Astrocytoma, IDH-Wildtype
  • +8 more
  • Quality-of-Life Assessment
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
2021-11-17
Nov 17, 2021
W
Completed
  • Astrocytoma
  • +2 more
  • Hepatitis A Vaccine
  • +3 more
  • Winston-Salem, North Carolina
    Comprehensive Cancer Center of Wake Forest University
2021-10-28
Oct 28, 2021
O
Not yet recruiting
  • Glioblastoma
  • +2 more
  • (no location specified)
2021-09-26
Sep 26, 2021
D
Recruiting
  • Malignant Glioma of Brain
  • +13 more
  • Boston, Massachusetts
  • +1 more
2021-08-09
Aug 9, 2021
S
Recruiting
  • Brain Tumor
  • +7 more
  • Three-dimensional printed model
  • Nijmegen, Gelderland, Netherlands
    Radboud University Medical Center
2021-07-10
Jul 10, 2021
N
Active, not recruiting
  • Glioma
  • +5 more
  • IMA950
  • +2 more
  • San Francisco, California
    University of California
2021-07-08
Jul 8, 2021
D
Recruiting
  • Astrocytoma
  • +8 more
    • Boston, Massachusetts
    • +3 more
    2021-05-30
    May 30, 2021
    H
    Recruiting
    • Oligodendroglioma
    • Proteomic analysis
    • Bron, France
    • +1 more
    2021-04-12
    Apr 12, 2021
    U
    Withdrawn
    • Anaplastic Oligodendroglioma
    • +2 more
    • Wear novoTTF-200A
    • Quality-of-Life Assessment
    • Los Angeles, California
      USC / Norris Comprehensive Cancer Center
    2020-12-08
    Dec 8, 2020
    M
    Recruiting
    • Astrocytoma
    • +11 more
    • ProTRAIT
    • Maastricht, Limburg, Netherlands
    • +2 more
    2020-11-23
    Nov 23, 2020
    U
    Completed
    • Oligoastrocytoma
    • +2 more
    • fMRI
    • +2 more
    • (no location specified)
    2020-09-01
    Sep 1, 2020
    J
    Withdrawn
    • Giant Cell Glioblastoma
    • +4 more
    • autologous dendritic cells pulsed with tumor lysate antigen Vaccine
    • +4 more
    • Los Angeles, California
      UCLA / Jonsson Comprehensive Cancer Center
    2020-07-22
    Jul 22, 2020
    E
    Active, not recruiting
    • Glioblastoma
    • +2 more
    • RRx-001 dose escalation with TMZ + RT
    • +3 more
    • San Francisco, California
    • +2 more
    2020-07-21
    Jul 21, 2020
    S
    Recruiting
    • Astrocytoma
    • +2 more
    • Guangzhou, Guangdong, China
      Sun Yat-sen University Cancer Center
    2020-05-26
    May 26, 2020